Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Joseph R Young
11 Sep 2026
SVP, Finance, Chief Acct Offcr
Exercised, kept
5,000
$3.94
$19.70K
Joseph R Young
13 Mar 2026
SVP, Finance, Chief Acct Offcr
Exercised, kept
10,000
$3.94
$39.40K
Joseph R Young
13 Nov 2025
SVP, Finance, Chief Acct Offcr
Exercised, kept
10,000
$3.94
$39.40K
Marshall Fordyce
19 Dec 2024
President and CEO
Exercised, kept
57,661
$2.90
$167.03K
Marshall Fordyce
29 Dec 2023
President and CEO
Exercised, kept
13,000
$2.90
$37.66K
Marshall Fordyce
29 Dec 2023
President and CEO
Exercised, kept
516
$2.32
$1.20K
Joseph R Young
5 Jul 2023
SVP, Finance, Chief Acct Offcr
Exercised, kept
10,000
$3.94
$39.40K
Marshall Fordyce
16 Nov 2022
President and CEO
Exercised, kept
60,000
$2.90
$173.81K
Marshall Fordyce
16 Nov 2022
President and CEO
Exercised, kept
5,153
$2.32
$11.94K

What was left out

Form 4 filings counted 193
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 139
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 16,126,126
Sales filed before the plan box existed 5
History held since 17 May 2021